Pasar al contenido principal

MICROCIRCUITOS Y MACROCIRCUITOS DE LA VIA TAC2 EN APRENDIZAJE DEL MIEDO

BES-2017-080870

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Formación
Convocatoria Contratos Predoctorales
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The PAC1 receptor risk genotype does not influence fear acquisition, extinction, or generalization in women with no trauma/low trauma

  • Velasco García, Eric Raúl|||0000-0002-8778-5618
  • Fabregat Nabás, Jaime|||0000-0002-5040-0913
  • Torrents-Rodas, David|||0000-0003-0222-7770
  • Arias, Barbara|||0000-0001-9181-2132
  • Torrúbia, Rafael|||0000-0002-6826-6572
  • Fullana, Miguel|||0000-0003-3863-5223
  • Andero Galí, Raül|||0000-0003-3641-8903
Women are known to have twice as much lifetime prevalence of post-traumatic stress disorder (PTSD) as men do. It has been reported that the risk genotype (CC) of a single nucleotide polymorphism (SNP) (rs2267735) in the pituitary adenylate cyclase-activating polypeptide (PACAP-PAC1R) system is associated with PTSD risk and altered fear conditioning and fear extinction in women. Surprisingly, no previous work has studied the effect of this SNP on fear conditioning, extinction, or generalization in non-traumatized/low trauma load women. Here, two separate groups of women underwent either a two-day fear conditioning and fear extinction paradigm, or a one-day fear conditioning and fear generalization paradigm. Results showed no significant differences between genotypes in conditioned stimulus discrimination, during fear acquisition, extinction, or generalization. These findings suggest that the previously reported fear processing impairments in traumatized CC women are not a consequence of this genotype alone, but likely dependent on the interaction between this genetic risk and the exposure to traumatic stressors.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Sex differences in fear memory consolidation via Tac2 signaling in mice

  • Florido Torres, Antonio Luis
  • Velasco, Eric R.
  • Soto-Faguás, Carlos M.
  • Gómez-Gómez, Àlex
  • Pérez-Caballero, Laura
  • Molina, Patricia
  • Nadal, Roser
  • Pozo Mendoza, Óscar J., 1975-
  • Saura, Carlos A.
  • Andero, Raül
Memory formation is key for brain functioning. Uncovering the memory mechanisms is helping us to better understand neural processes in health and disease. Moreover, more specific treatments for fear-related disorders such as posttraumatic stress disorder and phobias may help to decrease their negative impact on mental health. In this line, the Tachykinin 2 (Tac2) pathway in the central amygdala (CeA) has been shown to be sufficient and necessary for the modulation of fear memory consolidation. CeA-Tac2 antagonism and its pharmacogenetic temporal inhibition impair fear memory in male mice. Surprisingly, we demonstrate here the opposite effect of Tac2 blockade on enhancing fear memory consolidation in females. Furthermore, we show that CeA-testosterone in males, CeA-estradiol in females and Akt/GSK3β/β-Catenin signaling both mediate the opposite-sex differential Tac2 pathway regulation of fear memory., We would also like to thank Noemí Haro for help with estradiol determination. Procedural images were created with BioRender.com. RA was supported by a NARSAD Young Investigator Grant #22434, Ramón y Cajal program RYC2014-15784, RETOS-MICINN SAF2016-76565-R FEDER funds, and ERANET-Neuron JTC 2019 ISCIII AC19/00077. CAS is supported by Ministerio de Ciencia e Inovación (MICINN) grant SAF2016-80027-R, PID2019-106615RB-100, and ISCIII (CIBERNED CB06/05/0042). RN was supported by MICINNgrant SAF2017-83430 and was a recipient of an ICREA Academia Award (Generalitat de Catalunya, 2015-2019). AF 2018 FI_B00030 and CMS 2017 FI_B00326 were recipients of Generalitat de Catalunya predoctoral fellowship. ERV was supported by BES-2017-080870 FPI-2017 fellowship from MINECO. LPC was supported by an FJC2018-037958-I (MCIyU). PM received support from FPU16/05416 (MCECD). OP was supported by the Spanish Health National System CPII16/00027.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Sex differences in fear memory consolidation via Tac2 signaling in mice

  • Florido Torres, Antonio Luis
  • Velasco, Eric R.
  • Soto-Faguás, Carlos M.
  • Gómez-Gómez, Àlex
  • Pérez-Caballero, Laura
  • Molina, Patricia
  • Nadal, Roser
  • Pozo Mendoza, Óscar J., 1975-
  • Saura, Carlos A.
  • Andero, Raül
Memory formation is key for brain functioning. Uncovering the memory mechanisms is helping us to better understand neural processes in health and disease. Moreover, more specific treatments for fear-related disorders such as posttraumatic stress disorder and phobias may help to decrease their negative impact on mental health. In this line, the Tachykinin 2 (Tac2) pathway in the central amygdala (CeA) has been shown to be sufficient and necessary for the modulation of fear memory consolidation. CeA-Tac2 antagonism and its pharmacogenetic temporal inhibition impair fear memory in male mice. Surprisingly, we demonstrate here the opposite effect of Tac2 blockade on enhancing fear memory consolidation in females. Furthermore, we show that CeA-testosterone in males, CeA-estradiol in females and Akt/GSK3β/β-Catenin signaling both mediate the opposite-sex differential Tac2 pathway regulation of fear memory., We would also like to thank Noemí Haro for help with estradiol determination. Procedural images were created with BioRender.com. RA was supported by a NARSAD Young Investigator Grant #22434, Ramón y Cajal program RYC2014-15784, RETOS-MICINN SAF2016-76565-R FEDER funds, and ERANET-Neuron JTC 2019 ISCIII AC19/00077. CAS is supported by Ministerio de Ciencia e Inovación (MICINN) grant SAF2016-80027-R, PID2019-106615RB-100, and ISCIII (CIBERNED CB06/05/0042). RN was supported by MICINNgrant SAF2017-83430 and was a recipient of an ICREA Academia Award (Generalitat de Catalunya, 2015-2019). AF 2018 FI_B00030 and CMS 2017 FI_B00326 were recipients of Generalitat de Catalunya predoctoral fellowship. ERV was supported by BES-2017-080870 FPI-2017 fellowship from MINECO. LPC was supported by an FJC2018-037958-I (MCIyU). PM received support from FPU16/05416 (MCECD). OP was supported by the Spanish Health National System CPII16/00027.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex differences in fear memory consolidation via Tac2 signaling in mice

  • Florido Torres, Antonio Luis|||0000-0001-6184-0706
  • Velasco García, Eric Raúl|||0000-0002-8778-5618
  • Soto Faguas, Carlos Manuel|||0000-0003-2954-4987
  • Gomez-Gomez, A.|||0000-0001-8172-1827
  • Perez-Caballero, Laura|||0000-0002-2315-2213
  • Molina Molina, Patricia|||0000-0002-4118-4702
  • Nadal i Alemany, Roser|||0000-0001-8972-2525
  • Pozo, Oscar J.|||0000-0002-1735-9728
  • Saura Antolín, Carlos|||0000-0003-3692-5657
  • Andero Galí, Raül|||0000-0003-3641-8903
Memory formation is key for brain functioning. Uncovering the memory mechanisms is helping us to better understand neural processes in health and disease. Moreover, more specific treatments for fear-related disorders such as posttraumatic stress disorder and phobias may help to decrease their negative impact on mental health. In this line, the Tachykinin 2 (Tac2) pathway in the central amygdala (CeA) has been shown to be sufficient and necessary for the modulation of fear memory consolidation. CeA-Tac2 antagonism and its pharmacogenetic temporal inhibition impair fear memory in male mice. Surprisingly, we demonstrate here the opposite effect of Tac2 blockade on enhancing fear memory consolidation in females. Furthermore, we show that CeA-testosterone in males, CeA-estradiol in females and Akt/GSK3β/β-Catenin signaling both mediate the opposite-sex differential Tac2 pathway regulation of fear memory. The Tachykinin 2 (Tac2) pathway in the central amygdala is sufficient and necessary for modulating fear memory consolidation. The authors show that silencing Tac2 neurons in the amygdala of male mice reduces fear expression, while fear expression in female mice is increased when manipulations are made during proestrus.
Dipòsit Digital de Documents de la UAB
Datos de investigación Set de datos (Dataset)

Replication data for PACAP-PAC1R modulates fear extinction via the ventromedial hypothalamus

  • Velasco García, Eric Raúl|||0000-0002-8778-5618
  • Andero Galí, Raül|||0000-0003-3641-8903
This dataset includes the source data related to the submission of the article "PACAP-PAC1R modulates fear extinction via the ventromedial hypothalamus" to Nature Communications. It includes data about mRNA and protein regulation of PACAP-PAC1R system after a stress paradigm coupled with a fear conditioning and fear extinction task. The effects of stress circuitry chemogenetic manipulation over PACAP-PAC1R regulation are also shown. Data from two cohorts of human participants are included, in the first cohort, the effects of the menstrual cycle over post-traumatic symptoms were investigated. In the second cohort, the effects of PACAP1R genotype in the SNP rs2267735 were investigated in a fear extinction task.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

PACAP-PAC1R modulates fear extinction via the ventromedial hypothalamus

  • Velasco García, Eric Raúl|||0000-0002-8778-5618
  • Florido Torres, Antonio Luis|||0000-0001-6184-0706
  • Flores de los Heros, Africa|||0000-0003-0720-2409
  • Senabre, Eric|||0000-0001-8507-8154
  • Gomez-Gomez, A.|||0000-0001-8172-1827
  • Torres, Anna|||0000-0001-5178-1917
  • Roca Lecumberri, Alba|||0000-0002-9235-0723
  • Norrholm, S.
  • Newman, Emily L.|||0000-0003-0978-1600
  • Das, P.
  • Ross, R.A.
  • Lori, Adriana
  • Pozo, Oscar J.|||0000-0002-1735-9728
  • Ressler, Kerry J.|||0000-0002-5158-1103
  • García Esteve, Luisa|||0000-0002-2893-4409
  • Jovanovic, Tanja|||0000-0002-6456-0053
  • Andero Galí, Raül|||0000-0003-3641-8903
Exposure to traumatic stress can lead to fear dysregulation, which has been associated with posttraumatic stress disorder (PTSD). Previous work showed that a polymorphism in the PACAP-PAC1R (pituitary adenylate cyclase-activating polypeptide) system is associated with PTSD risk in women, and PACAP (ADCYAP1)-PAC1R (ADCYAP1R1) are highly expressed in the hypothalamus. Here, we show that female mice subjected to acute stress immobilization (IMO) have fear extinction impairments related to Adcyap1 and Adcyap1r1 mRNA upregulation in the hypothalamus, PACAP-c-Fos downregulation in the Medial Amygdala (MeA), and PACAP-FosB/ΔFosB upregulation in the Ventromedial Hypothalamus dorsomedial part (VMHdm). DREADD-mediated inhibition of MeA neurons projecting to the VMHdm during IMO rescues both PACAP upregulation in VMHdm and the fear extinction impairment. We also found that women with the risk genotype of ADCYAP1R1 rs2267735 polymorphism have impaired fear extinction.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Glucocorticoid-based pharmacotherapies preventing PTSD

  • Florido Torres, Antonio Luis|||0000-0001-6184-0706
  • Velasco, Eric Raúl
  • Monari, Sílvia
  • Cano, Marta|||0000-0003-0675-9483
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Sandi, Carmen|||0000-0001-7713-8321
  • Andero Galí, Raül|||0000-0003-3641-8903
  • Perez-Caballero, Laura|||0000-0002-2315-2213
Posttraumatic stress disorder (PTSD) is a highly disabling psychiatric condition that may arise after exposure to acute and severe trauma. It is a highly prevalent mental disorder worldwide, and the current treatment options for these patients remain limited due to low effectiveness. The time window right after traumatic events provides clinicians with a unique opportunity for preventive interventions against potential deleterious alterations in brain function that lead to PTSD. Some studies pointed out that PTSD patients present an abnormal function of the hypothalamic-pituitary-adrenal axis that may contribute to a vulnerability toward PTSD. Moreover, glucocorticoids have arisen as a promising option for preventing the disorder's development when administered in the aftermath of trauma. The present work compiles the recent findings of glucocorticoid administration for the prevention of a PTSD phenotype, from human studies to animal models of PTSD. Overall, glucocorticoid-based therapies for preventing PTSD demonstrated moderate evidence in terms of efficacy in both clinical and preclinical studies. Although clinical studies point out that glucocorticoids may not be effective for all patients' subpopulations, those with adequate traits might greatly benefit from them. Preclinical studies provide precise insight into the mechanisms mediating this preventive effect, showing glucocorticoid-based prevention to reduce long-lasting behavioral and neurobiological abnormalities caused by traumatic stress. However, further research is needed to delineate the precise mechanisms and the extent to which these interventions can translate into lower PTSD rates and morbidity.